Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/VTRS
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Viatris Inc (VTRS) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Viatris (VTRS) trades at $17.24, down 0.23% on the day, with a bullish technical signal from moving averages. The company has beaten EPS estimates for three consecutive quarters, though it reported a net loss of $3.51 billion in 2025. Positive Phase 3 results for VR-205 and an FDA-accepted NDA for a non-opioid pain therapy highlight pipeline progress. The stock appears undervalued with a P/S of 1.38 and a consensus price target of $20.00, representing a 16% upside.
The outlook is cautiously optimistic, driven by earnings beats and pipeline catalysts, but significant risks include persistent net losses, high debt levels, and potential regulatory headwinds from proposed generic drug tariffs. Analyst sentiment is mixed with a 'Hold' consensus, suggesting the stock offers value with execution-dependent upside.
Read full analysis

Key Stats

  • Market Cap
    $20.08B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $17.59
  • 52W Low
    $8.74
  • Typical Hold Time
    -
  • Enterprise Value
    $32.29B
  • Div Yield
    2.78%
  • Trading Activity
    -
$17.47
52W Low: $8.74
31 Jul 2025
52W High: $17.59
21 Jul 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $8.74 and a high of $17.59, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Most Recent News

Content is generated by Aura AI

Man Group PLC discloses 1.63% stake in Senior Plc via equity swaps as of July 24, 2026.

Man Group PLC has publicly disclosed holding a 1.63% interest in Senior Plc through cash-settled equity swaps as of July 24, 2026. This disclosure is made under Rule 8.3 of the UK Takeover Code, indicating a significant stake in the company. The posi...

Market News
34 minutes ago
Na
Neutral
pluang ai news

Blowing agent market to grow to $2.94B by 2035 driven by demand for eco-friendly insulation and regulations.

The global blowing agent market, valued at $1.79 billion in 2025, is projected to reach $2.94 billion by 2035 with a CAGR of 5.41%. Growth is fueled by increasing demand for low-global warming potential (GWP) insulation solutions, stricter environmen...

Market News
47 minutes ago
Sns Insider
Bullish
news icon
pluang ai news

Investec Bank discloses share trades for Gamma Communications on July 24, 2026.

Investec Bank plc, acting as joint broker for Gamma Communications Plc, disclosed public dealings involving the purchase and sale of 52,929 ordinary shares on July 24, 2026. The trades occurred within a price range of 941 to 956.75 per share. There w...

Market News
1 hour ago
Na
Neutral
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $20.08B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $17.59
  • 52W Low
    $8.74
  • Typical Hold Time
    -
  • Enterprise Value
    $32.29B
  • Div Yield
    2.78%
  • Trading Activity
    -
$17.47
52W Low: $8.74
31 Jul 2025
52W High: $17.59
21 Jul 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $8.74 and a high of $17.59, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!